Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Takeda Chooses PRA To Lead Its Revamped Clinical Development Ops

Executive Summary

Takeda has chosen US-based PRA Health Sciences to lead its clinical development as part of the Japanese drug maker’s global R&D overhaul aimed at cutting costs and improving efficiency and innovation.


Related Content

Entyvio Takes Lead As Takeda Pursues Turnaround
Refocus, Optimize, Externalize: Takeda Overhauls Global R&D
Kinder cuts: CRO deals palliate pharma downsizing


Related Companies